Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter

Blood

Volumn 89, Issue 1, 1997, Pages 176-182

  Arbini, Arnaldo A ^b   Pollak, Eleanor S ^b   Bayleran, Janet K ^b   High, Katherine A ^b   Bauer, Kenneth A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ARTICLE; BINDING SITE; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CHILD; FEMALE; GENE ISOLATION; GENE MUTATION; HUMAN; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING;

EID: 0031026003     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.1.176     Document Type: Article

References (38)

1. Osterud B, Rapaport SI: Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 74:5260, 1977
2. Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD: Factor IX is activated in vivo by the tissue factor mechanism. Blood 76:731, 1990
3. Pfeiffer RA, Ott A, Gilgenkrantz S, Alexandre P: Deficiency of coagulation factors VII and X associated with deletion of a chromosome 13 (q34). Evidence from two cases with 46,XY, t(13;Y)(q11;q34). Hum Genet 62:358, 1982
4. Miao CH, Leytus SP, Chung DW, Davie EW: Liver-specific expression of the gene coding for human factor X, a blood coagulation factor. J Biol Chem 267:7395, 1992
5. O'Hara PJ, Grant FJ, Haldeman BA, Gray CL, Insley MY, Hagen FS, Murray MJ: Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci USA 84:5158, 1987
6. Tuddenham EGD, Pemberton S, Cooper DN: Inherited factor VII deficiency: Genetics and molecular pathology. Thromb Haemost 74:313, 1995
7. 359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. Blood 87:5085, 1996
8. Erdmann D, Heim J: Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter. J Biol Chem 270:22988, 1995
9. Greenberg D, Miao CH, Ho WT, Chung DW, Davie EW: Liver-specific expression of the human factor VII gene. Proc Natl Acad Sci USA 92:12347, 1995
10. Pollak ES, Hung HL, Godin G, Overton GC, High KA: Functional characterization of the human factor VII 5′ flanking region. J Biol Chem 271:1738, 1996
11. Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH: Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proc Natl Acad Sci USA 89:6300, 1992
12. Huang MN, Hung HL, Stanfield-Oakley SA, High KA: Characterization of the human blood coagulation factor X promoter. J Biol Chem 267:15440, 1992
13. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jonew HW, Rary JM: Analysis of human Y chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245, 1977
14. Arbini AA, Bodkin D, Lopaciuk S, Bauer KA: Molecular analysis of Polish patients with factor VII deficiency. Blood 84:2214, 1994
15. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74:5463, 1977
16. Wu DY, Ugozzoli L, Pal BK, Wallace RB: Allele-specific enzymatic amplification of b-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci USA 86:2757, 1989
17. Seiden RF, Howie KB, Rowe ME, Goodman HM, Moore DD: Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol Cell Biol 6:3173, 1986
18. Sladek FM, Zhong W, Lai E, Darnell JE Jr: Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4:2353, 1990
19. Gorski K, Carneiro M, Schibler U: Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767, 1986
20. Bradford MM: A rapid and sensitive method for the quantitation of micrograms quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248, 1976
21. Chodosh L, Olesen J, Hahn S, Baldwin AS, Guarente L, Sharp P: A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell 53:25, 1988
22. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S: A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 11:540, 1991
23. Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F: A polymorphism in the 5′ region of coagulation factor VII (F7) caused by an inserted decanucleotide. Hum Genet 90:575, 1993
24. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, Zepponi E, Ursicino N, Chiarotti F, Mariani G: Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vase Biol 16:72, 1996
25. Humphries S, Temple A, Lane A, Green F, Cooper J. Miller G: Low plasma levels of Factor VIIc and antigen are more strongly associated with the 10 base promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost 75:567, 1996
26. Ragni MV, Lewis JH, Spero JA, Hasiba U: Factor VII deficiency. Am J Hematol 10:79, 1981
27. Triplett DA Brandt JT, McGann Batard MA, Schaeffer Dixon JL, Fair DS: Hereditary factor VII deficiency: Heterogeneity defined by combined functional and immunochemical analysis. Blood 66:1284, 1985
28. Goodrich JA, Cutler G, Tjian R: Contacts in context: Promoter specificity and macromolecular interactions in transcription. Cell 84:825, 1996
29. Hung HS: Molecular Basis of Liver-Specific Transcription of Human Blood Coagulation Factor X. Dissertation in Pathology, Philadelphia, PA, University of Pennsylvania, 1995
30. Malik S, Karathanasis SK: TFIIB-directed transcriptional activation by the orphan receptor Hepatocyte Nuclear Factor 4. Mol Cell Biol 16:1824, 1996
31. Salier JP, Hirosawa S, Kurachi K: Functional characterization of the 5′-regulatory region of human factor IX gene. J Biol Chem 265:7062, 1990
32. Picketts DJ, Mueller CR, Lillicrap D: Transcriptional control of the factor IX gene: Analysis of five cis-acting elements and the deleterious effect of naturally occurring hemophilia B Leyden mutations. Blood 84:2992, 1994
33. Briet E, Bertina RM, Van Tilburg NH, Veitkamp JJ: Hemophilia B Leyden. A sex-linked hereditary disorder that improves after puberty. N Engl J Med 306:788, 1982
34. Crossley M, Ludwig M, Stowell KM, De Vos P, Olek K, Brownlee GG: Recovery from hemophilia B Leyden: An androgen-responsive element in the factor IX promoter. Science 257:377, 1992
35. Briet E, Wignands MC, Veltkamp JJ: The prophylactic treatment of haemophilia B Leyden with anabolic steroids. Ann Intern Med 103:225, 1985
36. Hirosawa S. Fahner JB, Salier JP, Wu CT, Lovrien EW, Kurachi K: Structural and functional basis of the developmental regulation of human coagulation factor IX gene: Factor IX Leyden. Proc Natl Acad Sci USA 87:4421, 1990
37. Picketts DJ, Lillicrap DP, Mueller CR: Synergy between transcriptional factors DBP and C/EBP compensates for haemophilia B Leyden factor IX mutations. Nature Genet 3:175, 1993
38. Briet E, van Tilburg NH, Veltkamp JJ: Oral contraception and the detection of carriers in haemophilia B. Thromb Res 13:379, 1978